107 related articles for article (PubMed ID: 17224328)
1. Vitamin B6 (pyridoxamine) supplementation and complications of diabetes.
Jain SK
Metabolism; 2007 Feb; 56(2):168-71. PubMed ID: 17224328
[No Abstract] [Full Text] [Related]
2. Pyridoxamine: the many virtues of a maillard reaction inhibitor.
Voziyan PA; Hudson BG
Ann N Y Acad Sci; 2005 Jun; 1043():807-16. PubMed ID: 16037308
[TBL] [Abstract][Full Text] [Related]
3. Post-Amadori AGE inhibition as a therapeutic target for diabetic complications: a rational approach to second-generation Amadorin design.
Khalifah RG; Chen Y; Wassenberg JJ
Ann N Y Acad Sci; 2005 Jun; 1043():793-806. PubMed ID: 16037307
[TBL] [Abstract][Full Text] [Related]
4. [Role of oxidative stress in pathogenesis of diabetic microangiopathies].
Araki E; Nishikawa T
Nihon Rinsho; 2005 Jun; 63 Suppl 6():73-8. PubMed ID: 15999688
[No Abstract] [Full Text] [Related]
5. Preventing cell death induced by carbonyl stress, oxidative stress or mitochondrial toxins with vitamin B anti-AGE agents.
Mehta R; Shangari N; O'Brien PJ
Mol Nutr Food Res; 2008 Mar; 52(3):379-85. PubMed ID: 17918169
[TBL] [Abstract][Full Text] [Related]
6. Pyridoxamine (BioStratum).
Giannoukakis N
Curr Opin Investig Drugs; 2005 Apr; 6(4):410-8. PubMed ID: 15898348
[TBL] [Abstract][Full Text] [Related]
7. Novel approaches targeted toward oxidative stress for the treatment of chronic kidney disease.
Swaminathan S; Shah SV
Curr Opin Nephrol Hypertens; 2008 Mar; 17(2):143-8. PubMed ID: 18277146
[TBL] [Abstract][Full Text] [Related]
8. Propagation of protein glycation damage involves modification of tryptophan residues via reactive oxygen species: inhibition by pyridoxamine.
Chetyrkin SV; Mathis ME; Ham AJ; Hachey DL; Hudson BG; Voziyan PA
Free Radic Biol Med; 2008 Apr; 44(7):1276-85. PubMed ID: 18374270
[TBL] [Abstract][Full Text] [Related]
9. Pyridoxamine as a multifunctional pharmaceutical: targeting pathogenic glycation and oxidative damage.
Voziyan PA; Hudson BG
Cell Mol Life Sci; 2005 Aug; 62(15):1671-81. PubMed ID: 15905958
[TBL] [Abstract][Full Text] [Related]
10. Effects of pyridoxamine (K-163) on glucose intolerance and obesity in high-fat diet C57BL/6J mice.
Hagiwara S; Gohda T; Tanimoto M; Ito T; Murakoshi M; Ohara I; Yamazaki T; Matsumoto M; Horikoshi S; Funabiki K; Tomino Y
Metabolism; 2009 Jul; 58(7):934-45. PubMed ID: 19427656
[TBL] [Abstract][Full Text] [Related]
11. Advanced glycation endproducts: what is their relevance to diabetic complications?
Ahmed N; Thornalley PJ
Diabetes Obes Metab; 2007 May; 9(3):233-45. PubMed ID: 17391149
[TBL] [Abstract][Full Text] [Related]
12. Pleiotropic effect of pyridoxamine on diabetic complications via CD36 expression in KK-Ay/Ta mice.
Murakoshi M; Tanimoto M; Gohda T; Hagiwara S; Ohara I; Toyoda H; Ishikawa Y; Horikoshi S; Tomino Y
Diabetes Res Clin Pract; 2009 Feb; 83(2):183-9. PubMed ID: 19144436
[TBL] [Abstract][Full Text] [Related]
13. Metabolic memory: implications for diabetic vascular complications.
Cooper ME
Pediatr Diabetes; 2009 Aug; 10(5):343-6. PubMed ID: 19490497
[No Abstract] [Full Text] [Related]
14. Aged garlic extract and S-allyl cysteine prevent formation of advanced glycation endproducts.
Ahmad MS; Pischetsrieder M; Ahmed N
Eur J Pharmacol; 2007 Apr; 561(1-3):32-8. PubMed ID: 17321518
[TBL] [Abstract][Full Text] [Related]
15. Oxidative stress mediates protein kinase C activation and advanced glycation end product formation in a mesangial cell model of diabetes and high protein diet.
Tuttle KR; Anderberg RJ; Cooney SK; Meek RL
Am J Nephrol; 2009; 29(3):171-80. PubMed ID: 18781061
[TBL] [Abstract][Full Text] [Related]
16. Advanced glycosylated end products-mediated activation of polymorphonuclear neutrophils in diabetes mellitus and associated oxidative stress.
Gupta A; Tripathi AK; Tripathi RL; Madhu SV; Banerjee BD
Indian J Biochem Biophys; 2007 Oct; 44(5):373-8. PubMed ID: 18341213
[TBL] [Abstract][Full Text] [Related]
17. Effects of pyridoxamine in combined phase 2 studies of patients with type 1 and type 2 diabetes and overt nephropathy.
Williams ME; Bolton WK; Khalifah RG; Degenhardt TP; Schotzinger RJ; McGill JB
Am J Nephrol; 2007; 27(6):605-14. PubMed ID: 17823506
[TBL] [Abstract][Full Text] [Related]
18. Chelation therapy: overlooked in the treatment and prevention of diabetes complications?
Frizzell N; Baynes JW
Future Med Chem; 2013 Jun; 5(10):1075-8. PubMed ID: 23795964
[No Abstract] [Full Text] [Related]
19. Dietary supplementation with a combination of alpha-lipoic acid, acetyl-L-carnitine, glycerophosphocoline, docosahexaenoic acid, and phosphatidylserine reduces oxidative damage to murine brain and improves cognitive performance.
Suchy J; Chan A; Shea TB
Nutr Res; 2009 Jan; 29(1):70-4. PubMed ID: 19185780
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the effect of oxidative stress and vitamin E supplementation on renal function in rats with streptozotocin-induced Type 1 diabetes.
Haidara MA; Mikhailidis DP; Rateb MA; Ahmed ZA; Yassin HZ; Ibrahim IM; Rashed LA
J Diabetes Complications; 2009; 23(2):130-6. PubMed ID: 18436458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
